<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/><div style="float:right;padding:0 0 15px 20px;margin:15px 0 20px 20px;width:300px">
 Cognitive Assessment &amp; Training for Alzheimer Disease Market
 <figure>
 <img src="https://ml.globenewswire.com/Resource/Download/21a87d9b-3531-4a3b-8a26-e25e9ea28363" title="Cognitive Assessment &amp; Training for Alzheimer Disease Market" alt="Cognitive Assessment &amp; Training for Alzheimer Disease Market" />
 <figcaption>Cognitive Assessment &amp; Training for Alzheimer Disease Market</figcaption>
 </figure>
</div>Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/6234843/cognitive-assessment-and-training-alzheimers?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=b69slx&amp;utm_campaign=2250787+-+Cognitive+Assessment+%26+Training+for+the+Global+Alzheimer%27s+Disease+Market+2026-2032+-+AI-Enhanced+Alzheimer%27s+Care+Shifts+Focus+to+Continuous+Monitoring+and+Biomarker-Integration&amp;utm_exec=jocamsai" rel="nofollow" target="_blank" title="Cognitive Assessment &amp; Training for Alzheimer's Disease Market by Offering Type, Delivery Mode, Technology Platform, Supervision Level, Disease Stage, End User, Age Group - Global Forecast 2026-2032">"Cognitive Assessment &amp; Training for Alzheimer's Disease Market by Offering Type, Delivery Mode, Technology Platform, Supervision Level, Disease Stage, End User, Age Group - Global Forecast 2026-2032"</a> has been added to ResearchAndMarkets.com's offering. The Cognitive Assessment &amp; Training for Alzheimer's Disease Market was valued at USD 805.23 million in 2025 and is projected to reach USD 886.48 million in 2026, with a continuous growth trajectory at a CAGR of 10.33%, reaching USD 1.60 billion by 2032. This market research report provides a comprehensive examination of industry trends, competitive landscapes, regional dynamics, and innovative technological advancements. Designed for decision-makers, this report offers insights crucial for strategic planning, competitive positioning, and risk mitigation in an evolving market environment. <img alt="" height="400" src="//www.researchandmarkets.com/content-images/2495/2495152/1/cognitive-assessment-and-training-for-alzheimer.png" width="600" /> Market Evolution Driven by Technology and Regulatory Shifts Cognitive assessment and training for Alzheimer's disease is undergoing a transformation due to the increasing demand for technology-enabled diagnosis and care pathways. The shift from paper-based testing to digital solutions is driven by the growing prevalence of Alzheimer's and the necessity for earlier identification and consistent follow-up. The FDA's clearance of a blood test for Alzheimer's diagnosis and the introduction of the CMS GUIDE Model are pivotal regulatory milestones that highlight the need for practical cognitive tools within integrated care workflows. Trends in Measurement and Evidence-Based Training There is a significant convergence between digital cognition and biomarker-informed decision-making, with the FDA's approval of blood-based aids underscoring the integration of cognitive testing into a multimodal evidence framework. Remote assessments via smartphones and smartwatches, as demonstrated by the Intuition brain health study, are becoming more credible and scalable, drawing attention to platforms that combine convenience, sensitivity, and interoperability. Cognitive training is also becoming more evidence-driven, with a sharp focus on stage-specific support and functionality enhancement rather than broad disease modification claims. Regional Dynamics and Opportunities Regional distinctions are shaping the market's evolution. In the Americas, the alignment of clinical validation with reimbursement models accelerates commercialization, particularly in the United States. Europe, Middle East &amp; Africa emphasize compliance with evidence standards, while Asia-Pacific's focus on digital reach and large aging populations presents unique opportunities. Vendors must tailor their strategies to local care systems, ensuring alignment with regional needs and evidence requirements. Competitive Landscape: Evidence and Integration Leading the Charge Competition within the market is increasingly centered on the ability to deliver validated cognitive measures and integrate these into care workflows. Companies like BrainCheck and Neurotrack stand out for their comprehensive cognitive solutions that emphasize operational efficiency and broad deployment capabilities. Meanwhile, innovators like Cogstate and Cambridge Cognition are pushing the boundaries of research-grade measurement and biomarker innovation. Competitive success hinges on platforms that offer multimodal integration rather than isolated cognitive assessments. Key Takeaways from This Report: <ul><li>The Cognitive Assessment &amp; Training for Alzheimer's Disease market is projected to reach USD 1.60 billion by 2032 at a CAGR of 10.33%.</li><li>Advancements in biomarker-linked diagnostic tools and digital measurement technologies are reshaping the market.</li><li>The U.S. tariffs are encouraging the shift towards software-led solutions over hardware-intensive configurations.</li><li>Regional strategies need to be tailored to local evidence and care requirements, with specific focus on the Americas, EMEA, and Asia-Pacific.</li><li>Competitive advantages lie in delivering validated measures integrated into care systems, rather than isolated cognitive assessments.</li></ul> Key Attributes <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Report Attribute</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">Details</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Forecast Period</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">2026-2032</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Estimated Market Value (USD) in 2026</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">$886.48 Million</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Forecasted Market Value (USD) by 2032</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">$1603.29 Million</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-left: solid black 1pt ; ">Compound Annual Growth Rate</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ">10.3%</td></tr><tr><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; ">Regions Covered</td><td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; ">Global</td></tr></table> Key Topics Covered 1. PREFACE 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Segmentation &amp; Coverage 1.4 Years Considered for the Study 1.5 Currency Considered for the Study 1.6 Language Considered for the Study 1.7 Key Stakeholders 2. RESEARCH METHODOLOGY 2.1 Introduction 2.2 Research Design 2.3 Primary Research 2.4 Secondary Research 2.5 Research Framework 2.6 Qualitative Analysis 2.7 Quantitative Analysis 2.8 Market Size Estimation 2.8.1 Top-Down Approach 2.8.2 Bottom-Up Approach 2.9 Data Triangulation 2.10 Research Outcomes 2.11 Research Assumptions 2.12 Research Limitations 3. EXECUTIVE SUMMARY 3.1 Introduction 3.2 CXO Perspective 3.3 Market Size &amp; Growth Trends 3.4 Market Share Analysis, 2025 3.5 FPNV Positioning Matrix, 2025 3.6 New Revenue Opportunities 3.7 Next-Generation Business Models 3.8 Industry Roadmap 4. MARKET OVERVIEW 4.1 Introduction 4.2 Industry Ecosystem &amp; Value Chain Analysis 4.2.1 Supply-Side Analysis 4.2.2 Demand-Side Analysis 4.2.3 Stakeholder Analysis 4.3 Porter's Five Forces Analysis 4.4 PESTLE Analysis 4.5 Market Outlook 4.5.1 Near-Term Market Outlook (0-2 Years) 4.5.2 Medium-Term Market Outlook (3-5 Years) 4.5.3 Long-Term Market Outlook (5-10 Years) 4.6 Go-to-Market Strategy 5. MARKET INSIGHTS 5.1 Consumer Insights &amp; End-User Perspective 5.2 Consumer Experience Benchmarking 5.3 Opportunity Mapping 5.4 Distribution Channel Analysis 5.5 Pricing Trend Analysis 5.6 Regulatory Compliance &amp; Standards Framework 5.7 ESG &amp; Sustainability Analysis 5.8 Disruption &amp; Risk Scenarios 5.9 Return on Investment &amp; Cost-Benefit Analysis 5.10 Cumulative Impact of United States Tariffs 2025 5.11 Cumulative Impact of Artificial Intelligence 2025 6. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY OFFERING TYPE 6.1 Standalone Assessment Solutions 6.1.1 Screening Assessments 6.1.2 Diagnostic Assessments 6.1.3 Longitudinal Monitoring Assessments 6.1.4 Treatment Response Assessments 6.2 Standalone Training Solutions 6.3 Integrated Assessment &amp; Training Solutions 6.4 Implementation &amp; Support Services 7. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY DELIVERY MODE 7.1 In-Person 7.2 Remote Synchronous 7.3 Remote Asynchronous 7.4 Hybrid 8. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY TECHNOLOGY PLATFORM 8.1 Web-Based Platforms 8.2 Mobile Application Platforms 8.3 Desktop Platforms 8.4 Tablet-Optimized Platforms 8.5 Immersive Platforms 9. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY SUPERVISION LEVEL 9.1 Self-Administered 9.2 Caregiver-Assisted 9.3 Clinician-Administered 9.4 Hybrid Supervision 10. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY DISEASE STAGE 10.1 Preclinical Alzheimer's Disease 10.2 Mild Cognitive Impairment Due To Alzheimer's Disease 10.3 Mild Alzheimer's Disease Dementia 10.4 Moderate Alzheimer's Disease Dementia 10.5 Severe Alzheimer's Disease Dementia 11. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY END USER 11.1 Hospitals And Health Systems 11.2 Specialty Clinics 11.3 Long-Term Care Providers 11.4 Home Care Organizations 11.5 Academic &amp; Research Institutions 11.6 Direct-To-Consumer Users 12. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY AGE GROUP 12.1 Below 50 Years 12.2 50-64 Years 12.3 65-79 Years 12.4 80 Years &amp; Above 13. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY REGION 13.1 Asia-Pacific 13.2 North America 13.3 Latin America 13.4 Europe 13.5 Middle East 13.6 Africa 14. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY GROUP 14.1 ASEAN 14.2 GCC 14.3 European Union 14.4 BRICS 14.5 G7 14.6 NATO 15. COGNITIVE ASSESSMENT &amp; TRAINING FOR ALZHEIMER'S DISEASE MARKET, BY COUNTRY 15.1 United States 15.2 Canada 15.3 Mexico 15.4 Brazil 15.5 United Kingdom 15.6 Germany 15.7 France 15.8 Russia 15.9 Italy 15.10 Spain 15.11 China 15.12 India 15.13 Japan 15.14 Australia 15.15 South Korea 16. COMPETITIVE LANDSCAPE 16.1 Market Concentration Analysis, 2025 16.1.1 Concentration Ratio (CR) 16.1.2 Herfindahl Hirschman Index (HHI) 16.2 Recent Developments &amp; Impact Analysis, 2025 16.3 Product Portfolio Analysis, 2025 16.4 Benchmarking Analysis, 2025 16.5 Neurotrack Technologies, Inc. 16.6 Cambridge Cognition Ltd 16.7 Cogstate Ltd. 16.8 EMOTIV Inc. 16.9 Cambridge Brain Sciences Inc. 16.10 Linus Health, Inc. 16.11 PAR, Inc. 16.12 Multi-Health Systems Inc. 16.13 BrainCheck, Inc. 16.14 Posit Science Corporation 16.15 Psychology Software Tools, Inc. 16.16 NeuronUP, S.L. 16.17 Lumos Labs, Inc. 16.18 Altoida, Inc. 16.19 CNS Vital Signs, LLC 16.20 Cognivue, Inc. 16.21 Constant Therapy, Inc. 16.22 Five Lives SAS 16.23 HUMANS MATTER, SAS 16.24 Medotrax GmbH 16.25 MoCA Test Inc. 16.26 neotiv GmbH 16.27 Neuroglee Health 16.28 Neurosteer Inc. 16.29 Pearson plc 16.30 ViewMind Inc. For more information about this report visit <a href="https://www.researchandmarkets.com/reports/6234843/cognitive-assessment-and-training-alzheimers?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=b69slx&amp;utm_campaign=2250787+-+Cognitive+Assessment+%26+Training+for+the+Global+Alzheimer%27s+Disease+Market+2026-2032+-+AI-Enhanced+Alzheimer%27s+Care+Shifts+Focus+to+Continuous+Monitoring+and+Biomarker-Integration&amp;utm_exec=jocamsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/l5uli</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. 
 Attachment

<ul id="gnw_attachments_section-items">
 <li>
 <a target="_blank" href="https://ml.globenewswire.com/Resource/Download/21a87d9b-3531-4a3b-8a26-e25e9ea28363" title="Cognitive Assessment &amp; Training for Alzheimer Disease Market" rel="nofollow">Cognitive Assessment &amp; Training for Alzheimer Disease Market</a>
 </li>
 </ul>
<pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/ZjI0NWJmNTYtYmM2NS00ZDUzLWIzYjItYTQzODlkNGQ5NjRjLTEwMjY3MzctMjAyNi0wNS0xMy1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Cognitive Assessment & Training for the Global Alzheimer's Disease Market 2026-2032 - AI-Enhanced Alzheimer's Care Shifts Focus to Continuous Monitoring and Biomarker-Integration

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn